These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 9799757)

  • 21. [Correlation of lipoprotein(a) and ischemic heart disease].
    Kalina A
    Orv Hetil; 2002 Nov; 143(47):2625-9. PubMed ID: 12532648
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Fasting insulin and apolipoprotein B levels and low-density lipoprotein particle size as risk factors for ischemic heart disease.
    Lamarche B; Tchernof A; Mauriège P; Cantin B; Dagenais GR; Lupien PJ; Després JP
    JAMA; 1998 Jun; 279(24):1955-61. PubMed ID: 9643858
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Lipoprotein (a)--a mysterious factor in atherogenesis].
    Jelaković B; Laganović M; Kuzmanić D
    Lijec Vjesn; 2002; 124(11-12):366-71. PubMed ID: 12679978
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Carotid atherosclerosis and serum lipoprotein(a) concentrations in patients with NIDDM.
    Yamamoto M; Egusa G; Yamakido M
    Diabetes Care; 1997 May; 20(5):829-31. PubMed ID: 9135950
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Lipoprotein (a) as a risk factor for ischemic stroke: a meta-analysis.
    Nave AH; Lange KS; Leonards CO; Siegerink B; Doehner W; Landmesser U; Steinhagen-Thiessen E; Endres M; Ebinger M
    Atherosclerosis; 2015 Oct; 242(2):496-503. PubMed ID: 26298741
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Lipoprotein(a) and risk of sudden cardiac death in middle-aged Finnish men: A new prospective cohort study.
    Kunutsor SK; Khan H; Nyyssönen K; Laukkanen JA
    Int J Cardiol; 2016 Oct; 220():718-25. PubMed ID: 27393854
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The association of lipoprotein(a) with incident heart failure hospitalization: Atherosclerosis Risk in Communities study.
    Agarwala A; Pokharel Y; Saeed A; Sun W; Virani SS; Nambi V; Ndumele C; Shahar E; Heiss G; Boerwinkle E; Konety S; Hoogeveen RC; Ballantyne CM
    Atherosclerosis; 2017 Jul; 262():131-137. PubMed ID: 28554015
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Lipoprotein(a)-cholesterol and coronary heart disease in the Framingham Heart Study.
    Seman LJ; DeLuca C; Jenner JL; Cupples LA; McNamara JR; Wilson PW; Castelli WP; Ordovas JM; Schaefer EJ
    Clin Chem; 1999 Jul; 45(7):1039-46. PubMed ID: 10388480
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Pentanucleotide repeat polymorphism, lipoprotein(a) levels, and risk of ischemic heart disease.
    Kamstrup PR; Tybjaerg-Hansen A; Steffensen R; Nordestgaard BG
    J Clin Endocrinol Metab; 2008 Oct; 93(10):3769-76. PubMed ID: 18682504
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Small, dense low-density lipoprotein particles as a predictor of the risk of ischemic heart disease in men. Prospective results from the Québec Cardiovascular Study.
    Lamarche B; Tchernof A; Moorjani S; Cantin B; Dagenais GR; Lupien PJ; Després JP
    Circulation; 1997 Jan; 95(1):69-75. PubMed ID: 8994419
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Lipoprotein (a) and vascular disease: thrombogenesis and atherogenesis.
    Lip GY; Jones AF
    QJM; 1995 Aug; 88(8):529-39. PubMed ID: 7648239
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Lipoprotein Lp(a) excess and coronary heart disease.
    Stein JH; Rosenson RS
    Arch Intern Med; 1997 Jun; 157(11):1170-6. PubMed ID: 9183227
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Lipoprotein(a) Levels and Recurrent Vascular Events After First Ischemic Stroke.
    Lange KS; Nave AH; Liman TG; Grittner U; Endres M; Ebinger M
    Stroke; 2017 Jan; 48(1):36-42. PubMed ID: 27856951
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Lipoprotein(a) as a marker for coronary heart disease.
    Duriez P; Dallongeville J; Fruchart JC
    Br J Clin Pract Suppl; 1994 Dec; (77):51-8. PubMed ID: 19496273
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Lipoprotein(a) as a marker for coronary heart disease.
    Duriez P; Dallongeville J; Fruchart JC
    Br J Clin Pract Suppl; 1996 Jan; 77A():54-61. PubMed ID: 8729591
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Lipoprotein(a) and coronary heart disease. Meta-analysis of prospective studies.
    Danesh J; Collins R; Peto R
    Circulation; 2000 Sep; 102(10):1082-5. PubMed ID: 10973834
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Evolving lipoprotein risk factors: lipoprotein(a) and oxidized low-density lipoprotein.
    Jialal I
    Clin Chem; 1998 Aug; 44(8 Pt 2):1827-32. PubMed ID: 9702992
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Analysis of serum lipid levels in Japanese men and women according to body mass index. Increase in risk of atherosclerosis in postmenopausal women. Research Group on Serum Lipid Survey 1990 in Japan.
    Yamamoto A; Horibe H; Mabuchi H; Kita T; Matsuzawa Y; Saito Y; Nakaya N; Fujioka T; Tenba H; Kawaguchi A; Nakamura H; Goto Y
    Atherosclerosis; 1999 Mar; 143(1):55-73. PubMed ID: 10208480
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Plasma free fatty acid levels and the risk of ischemic heart disease in men: prospective results from the Québec Cardiovascular Study.
    Pirro M; Mauriège P; Tchernof A; Cantin B; Dagenais GR; Després JP; Lamarche B
    Atherosclerosis; 2002 Feb; 160(2):377-84. PubMed ID: 11849661
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Lipoprotein (a) levels and apolipoprotein (a) isoform size in patients with subclinical hypothyroidism: effect of treatment with levothyroxine.
    Milionis HJ; Efstathiadou Z; Tselepis AD; Bairaktari ET; Tsironis LD; Tsatsoulis A; Elisaf MS
    Thyroid; 2003 Apr; 13(4):365-9. PubMed ID: 12804105
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.